This inventor holds 8 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignee: Philogen S.p.a.. Active years: 2017-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Baden, CH (2017 - 2021)
- Neuenhof, CH (2018 - 2022)
- Otelfingen, CH (2023)
Company Filing History:
Years Active: 2017-2023
Title: **The Innovations of Sarah Wulhfard: Pioneering Cancer Treatments**
Introduction
Sarah Wulhfard, an esteemed inventor based in Baden, Switzerland, has made remarkable contributions to the field of biomedicine. With a portfolio of eight patents, her work primarily focuses on innovative solutions for cancer treatment and diagnosis. Her groundbreaking inventions are at the forefront of medical research, offering hope for improved therapeutic strategies.
Latest Patents
Wulhfard's most recent patents highlight her dedication to combating cancer through targeted therapies. One notable invention pertains to the development of antibodies to tumor antigens, specifically targeting carbonic anhydrase IX (CAIX). This patent emphasizes the potential for using specific binding members to treat, diagnose, and detect solid tumors. Furthermore, these binding members can be conjugated with biocidal or cytotoxic molecules to enhance their efficacy.
Another significant innovation from Wulhfard involves IL2 and TNF immunoconjugates, which comprise interleukin 2 (IL2) and tumor necrosis factor (TNF). By combining these components with an antibody that binds to antigens associated with neoplastic growth, such as the Extra-Domain A (EDA) of fibronectin, this invention opens new avenues for cancer treatment.
Career Highlights
At Philogen S.p.a., where she currently works, Wulhfard has established herself as a leading figure in the research and development of innovative therapeutic solutions. Her commitment to improving patient outcomes through scientific advancements has solidified her reputation in the medical community.
Collaborations
Collaboration plays a crucial role in Wulhfard's career. She has worked alongside notable colleagues, including Roberto De Luca and Francesca Pretto, fostering a culture of teamwork and innovation. These partnerships have enhanced her research efforts, leading to significant breakthroughs in cancer therapy.
Conclusion
Sarah Wulhfard's contributions to the field of cancer treatment and diagnosis exemplify the power of innovation in medicine. Through her patents and collaborative work at Philogen S.p.a., she continues to pave the way for new therapeutic strategies, offering hope to countless patients worldwide. Her dedication to advancing healthcare through innovative inventions underscores the vital role of researchers and inventors in shaping the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile